the same day, however, a study by chinese researchers published in the lancet found remdesivir didn't do better than a placebo when treating seriously ill covid-19 patients on such measures like time to clinical improvement.
the same day, however, a study by chinese researchers published in the lancet found remdesivir didn't do better than a placebo when treating seriously ill covid-19 patients on such measures like time to clinical improvement.